National Health (Listed drugs on F1 or F2) Amendment Determination 2016 (No. 6) (PB 57 of 2016) (Cth)

PB 57 of 2016

National Health (Listed drugs on F1 or F2) Amendment Determination 2016 (No. 6)

National Health Act 1953

I, DIANNA PROSSER, Assistant Secretary (Acting), Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated        22nd June 2016

DIANNA PROSSER

Assistant Secretary (Acting)
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health

Part 1         Preliminary

1. Name of Determination

   (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2016 (No. 6).

   (2)   This Determination may also be cited as PB 57 of 2016.

2. Commencement

   This Determination commences on 1 July 2016.

3. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

   Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Ambrisentan

Omit

Amino acid formula with vitamins and minerals without phenylalanine

Insert

Amino acid formula with carbohydrate, vitamins, minerals and trace elements without phenylalanine

Amino acid formula with fat, carbohydrate, vitamins, minerals and long chain polyunsaturated fatty acids without phenylalanine and supplemented with docosahexaenoic acid

[2]     Schedule 1, after item dealing with Amino acid formula with vitamins and minerals without methionine, threonine and valine, and low in isoleucine

Insert

Amino acid formula with vitamins and minerals without phenylalanine